Further research should focus on the regulatory mechanism of NLRP3 inflammasome in dry eye inflammation; the function of IL-18 in dry eye; and whether inhibition of inflammasome components can serve as a viable target for therapeutic development in dry eye. Here, IL18 is linked to Keratoconjunctivitis sicca.